A Sacrococcygeal Teratoma (SCT) is a rare medical miracle that occurs in newborn babies, usually in the first month of life. It is an abnormal growth that develops in the area of the baby’s tailbone. It is most often benign, meaning it is non-cancerous, but can also be malignant, or cancerous. In either case, it is a medical emergency that requires immediate attention. SCTs are classified as either type 1 or type 2. Type 1 SCTs are typically benign and occur in the lower portion of the tailbone. Type 2 SCTs are more likely to be malignant and occur higher up in the tailbone. Both types can cause serious health problems for the baby, including breathing difficulties, developmental delays, and even death.
The exact cause of SCT is unknown, but it is believed to be related to genetic factors. It is also thought that environmental factors, such as exposure to certain chemicals or radiation, may play a role.
SCTs are diagnosed through a physical exam and imaging tests such as ultrasound or magnetic resonance imaging (MRI). Treatment depends on the size and type of the tumor, as well as the age and overall health of the baby. For type 1 SCTs, the tumor is usually surgically removed. In some cases, chemotherapy or radiation may be used to shrink the tumor before surgery. For type 2 SCTs, the tumor may be treated with chemotherapy or radiation, or the entire tumor may be surgically removed.
The outlook for babies with SCTs is generally good. With prompt diagnosis and treatment, most babies make a full recovery. However, there is a risk of complications, including infection, bleeding, and organ damage. In some cases, the tumor may recur or spread to other parts of the body.
A Sacrococcygeal Teratoma is a rare medical miracle that can occur in newborn babies. It is classified as either type 1 or type 2, with type 1 being the more common and benign form. Diagnosis and treatment depend on the size and type of the tumor, as well as the age and overall health of the baby. With prompt diagnosis and treatment, most babies make a full recovery, although there is a risk of complications.
1.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
2.
Radiation therapy can promote amphiregulin, which increases growth of metastases
3.
Severe obesity associated with reduced prevalence of recommended cancer screenings
4.
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
5.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
1.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
2.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
3.
The Pros and Cons of Steroid Therapy for ITP
4.
Understanding Mean Corpuscular Volume: A Comprehensive Guide
5.
Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Navigating the Complexities of Ph Negative ALL - Part IV
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation